Latest hybrid closed‐loop systems aim to minimise hypoglycaemia and hyperglycaemia and maintain glucose levels within a target range through use of a computerised algorithm to adjust the basal rate of insulin and administer corrective bolus doses. Here, INS is linked to Hyperglycemia.